Annual Progress Review of Gynecologic Malignancies in 2025
|更新时间:2026-01-28
|
Annual Progress Review of Gynecologic Malignancies in 2025
“In 2025, global gynecological tumor research will focus on three major types of tumors, with breakthroughs in original achievements in China, providing new solutions for diagnosis and treatment.”
Chin Oncol(2026)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Received:04 January 2026,
Revised:2026-01-19,
稿件说明:
移动端阅览
Annual Progress Review of Gynecologic Malignancies in 2025[J/OL]. Chin Oncol, 2026.
DOI:
Annual Progress Review of Gynecologic Malignancies in 2025[J/OL]. Chin Oncol, 2026.DOI:
Annual Progress Review of Gynecologic Malignancies in 2025
Progress in treatment of gynecological cancer in 2023
The latest progress and prospect of gynecological tumor treatment at 2023 ESMO
Progress in diagnosis and treatment of gynecological tumors in 2022
Progress in menopausal hormone therapy for postoperative patients with gynecological malignant cancer
Leading research progress and prospect of gynecological oncology in 2020
Related Author
Zheng FENG
Qinhao GUO
Jun ZHU
Xiaohua WU
Hao WEN
Lingfang XIA
Min YU
Mingming ZHAO
Related Institution
Department of Gynecological Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University
复旦大学附属肿瘤医院妇瘤科,复旦大学上海医学院肿瘤学系
Department of Obstetrics and Gynecology, The Fourth Hospital of Changsha (Integrated Traditional Chinese and Western Medicine Hospital of Changsha, Changsha Hospital of Hunan Normal University)
Department of Pharmacy, Minhang Branch, Fudan University Shanghai Cancer Center